bretylium has been researched along with cromakalim in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berry, JL; Edwards, G; Hollingsworth, M; Hughes, SJ; Miller, AJ; Small, RC; Smith, RD; Weston, AH | 1 |
Chen, PS; Garfinkel, A; Karagueuzian, HS; Kil, JR; Kim, YH; Lee, MH; Qu, Z; Voroshilovsky, O; Weiss, JN | 1 |
2 other study(ies) available for bretylium and cromakalim
Article | Year |
---|---|
Inhibition by adrenergic neurone blocking agents of the relaxation induced by BRL 38227 in vascular, intestinal and uterine smooth muscle.
Topics: Animals; Aorta, Thoracic; Benzopyrans; Bretylium Compounds; Cromakalim; Female; Guanethidine; Guinea Pigs; Intestines; Male; Muscle Relaxation; Muscle, Smooth; Muscle, Smooth, Vascular; Nitroprusside; Norepinephrine; Potassium Chloride; Pyrroles; Rats; Rats, Sprague-Dawley; Sympatholytics; Theophylline; Uterine Contraction | 1992 |
Preventing ventricular fibrillation by flattening cardiac restitution.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiac Pacing, Artificial; Computer Simulation; Cromakalim; Diastole; Drug Design; Drug Evaluation, Preclinical; Fluorescent Dyes; Heart Conduction System; Models, Biological; Pyridinium Compounds; Swine; Ventricular Fibrillation | 2000 |